(Q34139700)

English

APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

cognitive dysfunction

1 reference

based on heuristic

inferred from title

mild cognitive impairment

1 reference

based on heuristic

inferred from title

author name string

Roger A Dixon

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Correne A DeCarlo

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Stuart W S MacDonald

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

David Vergote

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jack Jhamandas

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

David Westaway

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

5 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Frontiers in Aging Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

236

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein E.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Cognitively elite, cognitively normal, and cognitively impaired aging: neurocognitive status and stability moderate memory performance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

IDE (rs6583817) polymorphism and pulse pressure are independently and interactively associated with level and change in executive function in older adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Monetary costs of dementia in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

The neuropsychology of normal aging and preclinical Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Genetic effects on old-age cognitive functioning: a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Preclinical Alzheimer disease-the challenges ahead

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Development of isotope labeling LC-MS for human salivary metabolomics and application to profiling metabolome changes associated with mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

The economics of mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Mild cognitive impairment: a subset of minor neurocognitive disorder?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Lifestyle and genetic contributions to cognitive decline and hippocampal structure and function in healthy aging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Mild cognitive impairment is associated with selected functional markers: integrating concurrent, longitudinal, and stability effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

The association of APOE genotype with cognitive function in persons aged 35 years or older

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

BDNF Val66Met and cognition: all, none, or some? A meta-analysis of the genetic association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

COMT Val158Met Genotype and Individual Differences in Executive Function in Healthy Adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Neurogenetic effects on cognition in aging brains: a window of opportunity for intervention?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Fine-mapping of the brain-derived neurotrophic factor (BDNF) gene supports an association of the Val66Met polymorphism with episodic memory

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Changing perspectives regarding late-life dementia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Characterizing executive functioning in older special populations: from cognitively elite to cognitively impaired

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

The impact of genetic research on our understanding of normal cognitive ageing: 1995 to 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Age-related decline in brain resources modulates genetic effects on cognitive functioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

New insights into brain BDNF function in normal aging and Alzheimer disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Neurocognitive markers of cognitive impairment: exploring the roles of speed and inconsistency.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

The molecular genetics of cognition: dopamine, COMT and BDNF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Investigating cognitive genetics and its implications for the treatment of cognitive deficit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

5 July 2018

Characterizing mild cognitive disorders in the young-old over 8 years: prevalence, estimated incidence, stability of diagnosis, and impact on IADLs.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Mild cognitive impairment in a community sample: the Sydney Memory and Ageing Study.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Episodic memory change in late adulthood: generalizability across samples and performance indices.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

The genetics of cognitive ability and cognitive ageing in healthy older people.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

APOE genotype and cognitive functioning in a large age-stratified population sample.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Genetic and lifestyle predictors of 15-year longitudinal change in episodic memory.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Apolipoprotein E genotype and lifetime cognitive decline.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Risk factors for transitions from normal to mild cognitive impairment and dementia.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

The apolipoprotein E gene and its age-specific effects on cognitive function

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Shared genetic aetiology between cognitive ability and cardiovascular disease risk factors: Generation Scotland's Scottish family health study

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Age-Related Slowing of Digit Symbol Substitution Revisited: What Do Longitudinal Age Changes Reflect?

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

MCI is a clinically useful concept.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Apolipoprotein E and cognitive performance: a meta-analysis.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Including persistency of impairment in mild cognitive impairment classification enhances prediction of 5-year decline

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis.

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4155788

28 October 2018

Mild cognitive impairment

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Optimizing cognitive development over the life course and preventing cognitive decline: Introducing the Cognitive Health Environment Life Course Model (CHELM)

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

The Victoria Longitudinal Study: From Characterizing Cognitive Aging to Illustrating Changes in Memory Compensation

1 reference

https://api.crossref.org/works/10.3389%2FFNAGI.2014.00236

21 January 2018

Classification criteria for mild cognitive impairment: a population-based validation study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25249975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3389/FNAGI.2014.00236

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34139700&oldid=1598856228"